MitoSyne FollicleLight LLLT Hair-Growth Cap

A hands-free low-level light device with a defined optical dose, treatment schedule and device-specific indication.

FollicleLight keeps wavelength, coverage, session timing and regulatory context attached to the exact device.

A closer look

FollicleLight uses low-level red light in a hands-free cap with a fixed treatment schedule and automatic session timing. Device-level details matter in this category: wavelength, emitter count, scalp coverage, optical dose and fit all shape the exposure. Those specifications remain connected to the exact model and its cleared indication rather than being borrowed from another light device. Meta-analyses report increased hair density in adults with androgenetic alopecia compared with placebo, while also showing substantial variation between devices and studies. FollicleLight explains who the evidence applies to, the schedule used and the time results may take, without implying a cure for every form of hair loss.

The details that matter

• Exact FDA-cleared model and indication
• Verified emitter wavelength, count, coverage and optical dose
• Hands-free timed sessions with automatic shutoff
• Fit system that maintains consistent scalp distance
• Documented treatment schedule, cleaning and replacement policy

Why it belongs

FollicleLight belongs where optical specifications, device identity and the narrow evidence base can be examined together rather than reduced to a red-light label.

What the evidence supports

Meta-analysis reports improved hair density in androgenetic alopecia, with high heterogeneity. Evidence does not cover every alopecia type or every red-light cap.

What it is designed to do

Intended for pattern hair loss only within the exact device's cleared indication, schedule and labeling.

Use and care

Hair loss can have medical causes. Users should seek evaluation for sudden, patchy, scarring or symptomatic loss. Follow all light-sensitivity and contraindication labeling for the exact device.